MORGAN STANLEY - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 25 filers reported holding SYNTHETIC BIOLOGICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q2 2022$1,0000.0%2,982
+10.2%
0.00%
Q1 2022$1,000
-83.3%
2,706
-87.2%
0.00%
Q4 2021$6,000
-40.0%
21,091
+0.0%
0.00%
Q3 2021$10,00021,084
+8300.0%
0.00%
Q2 2021$02510.0%0.00%
Q1 2021$0251
+24.9%
0.00%
Q4 2020$02010.0%0.00%
Q3 2020$02010.0%0.00%
Q2 2020$0201
-58.7%
0.00%
Q1 2020$0487
+69.7%
0.00%
Q4 2019$0287
+32.9%
0.00%
Q3 2019$02160.0%0.00%
Q2 2019$0216
-44.5%
0.00%
Q1 2019$0389
-33.4%
0.00%
Q4 2018$0
-100.0%
584
-4.7%
0.00%
Q3 2018$1,0006130.00%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
MSD Partners, L.P. 960,680$655,0000.02%
Virtu Financial LLC 466,704$318,0000.02%
tru Independence LLC 60,000$30,0000.01%
Jacobi Capital Management LLC 18,500$13,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 109,300$75,0000.00%
Focused Wealth Management, Inc 500$00.00%
UBS Group AG 576,927$393,0000.00%
Stratos Wealth Partners, LTD. 10,850$7,0000.00%
NewEdge Advisors, LLC 14,187$10,0000.00%
Sowell Financial Services LLC 74$00.00%
View complete list of SYNTHETIC BIOLOGICS INC shareholders